Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues-Reference-Cited by-同舟云学术

Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues

Published:2024-05 Issue:9 Volume:10 Page:e30365
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Desmoulin Anissa^ORCID,Sababadichetty Loïk,Kamus Laure,Daniel Marion,Feletti Lucie,Allou Nicolas,Potron Anaïs,Leroy Anne-Gaëlle,Jaffar-Bandjee Marie-Christine,Belmonte Olivier,Garrigos Thomas,Miltgen Guillaume

Publisher

Elsevier BV

Reference18 articles.

1. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis;Cassini;Lancet Infect. Dis.,2019

2. In vitro activity of cefiderocol, a siderophore cephalosporin, against multidrug-resistant gram-negative bacteria;Mushtaq;Antimicrob. Agents Chemother.,2020

3. Re: “Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections” by Hoellinger et al;Larcher;Clin. Microbiol. Infect.,2023

4. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial;Bassetti;Lancet Infect. Dis.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak;Antibiotics;2024-08-15

2. New Agents Are Coming, and So Is the Resistance;Antibiotics;2024-07-13